Médica Sur, S.A.B. de C.V. (BMV:MEDICA.B)
54.00
0.00 (0.00%)
Nov 13, 2026, 2:44 PM CST
Médica Sur Ratios and Metrics
Market cap in millions MXN. Fiscal year is January - December.
Millions MXN. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,829 | 6,476 | 3,670 | 4,386 | 4,015 | 5,906 | |
Market Cap Growth | -4.09% | 76.47% | -16.32% | 9.22% | -32.01% | 42.59% |
Enterprise Value | 5,153 | 5,928 | 3,719 | 4,748 | 3,872 | 5,841 |
Last Close Price | 54.00 | 58.45 | 31.97 | 36.78 | 28.74 | 21.37 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.48 | 11.99 | 7.95 | 6.91 | 4.23 | 5.12 |
Forward PE | - | 8.45 | 8.45 | 8.45 | 6.44 | 9.45 |
PS Ratio | 1.23 | 1.35 | 0.83 | 1.06 | 1.04 | 1.55 |
PB Ratio | 2.12 | 2.57 | 1.57 | 2.15 | 1.59 | 1.20 |
P/TBV Ratio | 2.24 | 2.72 | 1.67 | 2.31 | 1.68 | 1.23 |
P/FCF Ratio | 12.96 | 8.07 | 6.98 | 20.35 | 53.00 | 8.81 |
P/OCF Ratio | 9.91 | 6.71 | 5.54 | 10.22 | 15.31 | 7.19 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.09 | 1.24 | 0.85 | 1.15 | 1.00 | 1.53 |
EV/EBITDA Ratio | 5.49 | 6.03 | 5.65 | 6.05 | 5.35 | 7.21 |
EV/EBIT Ratio | 6.86 | 7.40 | 7.72 | 7.61 | 6.71 | 7.95 |
EV/FCF Ratio | 11.46 | 7.38 | 7.07 | 22.03 | 51.11 | 8.72 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.38 | 0.40 | 0.45 | 0.52 | 0.42 | 0.22 |
Debt / EBITDA Ratio | 1.10 | 1.01 | 1.55 | 1.31 | 1.42 | 1.19 |
Debt / FCF Ratio | 2.29 | 1.26 | 1.99 | 4.87 | 13.92 | 1.61 |
Net Debt / Equity Ratio | -0.25 | -0.21 | -0.03 | 0.17 | -0.07 | -0.50 |
Net Debt / EBITDA Ratio | -0.73 | -0.54 | -0.12 | 0.44 | -0.23 | -3.03 |
Net Debt / FCF Ratio | -1.50 | -0.67 | -0.15 | 1.60 | -2.20 | -3.66 |
Asset Turnover | 0.98 | 1.04 | 1.03 | 0.95 | 0.67 | 0.57 |
Inventory Turnover | 31.58 | 29.40 | 23.66 | 19.90 | 19.39 | 16.63 |
Quick Ratio | 1.80 | 1.49 | 0.71 | 1.06 | 1.53 | 3.97 |
Current Ratio | 1.91 | 1.59 | 0.78 | 1.22 | 1.69 | 4.12 |
Return on Equity (ROE) | 19.17% | 22.20% | 19.29% | 24.47% | 12.72% | 8.01% |
Return on Assets (ROA) | 9.68% | 10.90% | 7.05% | 8.96% | 6.24% | 6.92% |
Return on Invested Capital (ROIC) | 24.28% | 25.40% | 14.74% | 19.82% | 16.72% | 11.90% |
Return on Capital Employed (ROCE) | 19.70% | 22.30% | 20.00% | 20.20% | 16.10% | 12.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.71% | 8.34% | 12.57% | 14.48% | 23.65% | 19.55% |
FCF Yield | 7.72% | 12.40% | 14.33% | 4.92% | 1.89% | 11.35% |
Dividend Yield | 2.96% | 2.67% | 4.41% | 3.69% | 89.69% | 4.15% |
Payout Ratio | 28.73% | 27.21% | 32.74% | 103.82% | 317.95% | 14.00% |
Buyback Yield / Dilution | 1.89% | - | - | - | 12.45% | - |
Total Shareholder Return | 4.85% | 2.67% | 4.41% | 3.69% | 102.13% | 4.15% |